Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Levels of Marine n-3 Polyunsaturated Fatty Acids in Plasma Phospholipids as a Prognostic Marker of Mortality and Graft Loss Endpoints in Renal Transplant Recipients.

NCT02017990 is registered in ClinicalTrials.gov with Oslo University Hospital as lead sponsor.

NCT NCT02017990
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02017990 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Levels of Marine n-3 Polyunsaturated Fatty Acids in Plasma Phospholipids as a Prognostic Marker of Mortality and Graft Loss Endpoints in Renal Transplant Recipients.
Lead sponsor
Oslo University Hospital
Phase
Observational
Overall status
Completed
Start date
October 31, 1999
Completion date
June 30, 2013
Enrollment
2,002 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

disorder of transplanted kidney